Business Description
Staar Surgical Co
NAICS : 339115
SIC : 3851
ISIN : US8523123052
Share Class Description:
STAA: Ordinary SharesDescription
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses which are used in surgery that treat cataracts. The company offers two types of products which are Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.16 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 1.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 14.94 | |||||
| Beneish M-Score | -2.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 24.1 | |||||
| 3-Year EBITDA Growth Rate | 48.3 | |||||
| 3-Year EPS without NRI Growth Rate | 61.9 | |||||
| 3-Year Book Growth Rate | 23 | |||||
| Future 3-5Y Total Revenue Growth Rate | 13.49 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.01 | |||||
| 9-Day RSI | 54.24 | |||||
| 14-Day RSI | 58.45 | |||||
| 6-1 Month Momentum % | -4.1 | |||||
| 12-1 Month Momentum % | -45.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.62 | |||||
| Quick Ratio | 5.08 | |||||
| Cash Ratio | 3.39 | |||||
| Days Inventory | 150.3 | |||||
| Days Sales Outstanding | 96.78 | |||||
| Days Payable | 56.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | -0.04 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.36 | |||||
| Operating Margin % | 8.72 | |||||
| Net Margin % | 6.62 | |||||
| FCF Margin % | -1.11 | |||||
| ROE % | 5.95 | |||||
| ROA % | 4.77 | |||||
| ROIC % | 8.43 | |||||
| ROC (Joel Greenblatt) % | 16.97 | |||||
| ROCE % | 7.15 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 109.21 | |||||
| Forward PE Ratio | 164.96 | |||||
| PE Ratio without NRI | 69.26 | |||||
| Shiller PE Ratio | 313.07 | |||||
| PEG Ratio | 1.96 | |||||
| PS Ratio | 7.19 | |||||
| PB Ratio | 5.94 | |||||
| Price-to-Tangible-Book | 5.97 | |||||
| Price-to-Operating-Cash-Flow | 157.59 | |||||
| EV-to-EBIT | 75.41 | |||||
| EV-to-EBITDA | 63.78 | |||||
| EV-to-Forward-EBITDA | 59.86 | |||||
| EV-to-Revenue | 6.57 | |||||
| EV-to-Forward-Revenue | 6.25 | |||||
| EV-to-FCF | -589.56 | |||||
| Price-to-Projected-FCF | 4.55 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.77 | |||||
| Price-to-Graham-Number | 4.29 | |||||
| Price-to-Net-Current-Asset-Value | 8.73 | |||||
| Price-to-Net-Cash | 19.4 | |||||
| Earnings Yield (Greenblatt) % | 1.33 | |||||
| FCF Yield % | -0.16 | |||||
| Forward Rate of Return (Yacktman) % | 20.61 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers